Browsing: Longevity

Company’s osteoporosis program completes enrollment in Phase 2 trial focused on treating the disease in postmenopausal women. US biotech Angitia…

Once-a-month shot delivers meaningful weight loss, but Wall Street remains uneasy about competition, tolerability and timing. Pfizer’s obesity moment finally…

New data link low-dose mTOR inhibition to DNA protection in aging immune cells, reframing how rapamycin’s healthspan effects might work.…

Dutch biotech and leading neuroscience lab team up to explore a new way of protecting brain cells by fixing the…

Ambr founder on how the startup is targeting population health with a prevention platform powered by ‘explainable AI.’ Norwegian healthtech…

Luffu targets collective health and wellbeing across families by tracking changes to normal ‘rhythms’ over time. With the longevity conversation…

Longevity Investors Lunch reflects a maturing field as science, capital and policy begin to converge beyond alpine optics. After years…

Death Clock adds AI-powered blood biomarker analysis and preventive health guidance in new Life Lab offering.   Provocatively-named digital health…

Big pharma AstraZeneca partners with Hong Kong’s CSPC to develop next-gen weight management drugs worldwide. Managing your weight is possible…

From peptides to stem cells, a physician shows how regenerative medicine is reshaping chronic pain and healthy aging in practice.…